Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization.

BACKGROUND Recent findings demonstrated that, in mammalian cells, telomere DNA (Tel) is transcribed into telomeric repeat-containing RNA (TERRA), which is involved in fundamental biological processes, thus representing a promising anticancer target. For this reason, the discovery of dual (as well as selective) Tel/TERRA G-quadruplex (G4) binders could represent an innovative strategy to enhance telomerase inhibition. METHODS Initially, docking simulations of known Tel and TERRA active ligands were performed on the 3D coordinates of bimolecular G4 Tel DNA (Tel2) and TERRA (TERRA2). Structure-based pharmacophore models were generated on the best complexes and employed for the virtual screening of ~257,000 natural compounds. The 20 best candidates were submitted to biophysical assays, which included circular dichroism and mass spectrometry at different K+ concentrations. RESULTS Three hits were here identified and characterized by biophysical assays. Compound 7 acts as dual Tel2/TERRA2 G4-ligand at physiological KCl concentration, while hits 15 and 17 show preferential thermal stabilization for Tel2 DNA. The different molecular recognition against the two targets was also discussed. CONCLUSIONS Our successful results pave the way to further lead optimization to achieve both increased selectivity and stabilizing effect against TERRA and Tel DNA G4s. GENERAL SIGNIFICANCE The current study combines for the first time molecular modelling and biophysical assays applied to bimolecular DNA and RNA G4s, leading to the identification of innovative ligand chemical scaffolds with a promising anticancer profile. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.

[1]  Stephen Neidle,et al.  Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.

[2]  Woody Sherman,et al.  Improving database enrichment through ensemble docking , 2008, J. Comput. Aided Mol. Des..

[3]  M. Komiyama,et al.  G-quadruplex formation by human telomeric repeats-containing RNA in Na+ solution. , 2008, Journal of the American Chemical Society.

[4]  Stefano Alcaro,et al.  Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches. , 2013, Journal of medicinal chemistry.

[5]  Shankar Balasubramanian,et al.  Visualization and selective chemical targeting of RNA G-quadruplex structures in the cytoplasm of human cells. , 2014, Nature chemistry.

[6]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[7]  G. Parkinson,et al.  Structural basis of telomeric RNA quadruplex--acridine ligand recognition. , 2011, Journal of the American Chemical Society.

[8]  Daniela Schuster,et al.  Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation , 2011, Bioorganic & medicinal chemistry.

[9]  A. Phan,et al.  Structure of propeller-type parallel-stranded RNA G-quadruplexes, formed by human telomeric RNA sequences in K+ solution. , 2009, Journal of the American Chemical Society.

[10]  N. Maizels,et al.  Dynamic roles for G4 DNA in the biology of eukaryotic cells , 2006, Nature Structural &Molecular Biology.

[11]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1953, Nature.

[12]  G. Parkinson,et al.  Selectivity in small molecule binding to human telomeric RNA and DNA quadruplexes. , 2009, Chemical communications.

[13]  E. De Pauw,et al.  Determination of affinity, stoichiometry and sequence selectivity of minor groove binder complexes with double-stranded oligodeoxynucleotides by electrospray ionization mass spectrometry. , 2002, Nucleic acids research.

[14]  Jiang Zhou,et al.  Mass spectrometry of G-quadruplex DNA: formation, recognition, property, conversion, and conformation. , 2011, Mass spectrometry reviews.

[15]  Yan Xu.  Human telomere RNA: a potential target for ligand recognition. , 2012, Current pharmaceutical design.

[16]  M. Komiyama,et al.  Structure, function and targeting of human telomere RNA. , 2012, Methods.

[17]  S. Balasubramanian,et al.  Quantitative visualization of DNA G-quadruplex structures in human cells. , 2013, Nature chemistry.

[18]  Laurence H. Hurley,et al.  Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. , 2008, Biochimie.

[19]  R. Zenobi,et al.  Mass spectrometric studies of dissociation constants of noncovalent complexes , 2011 .

[20]  E. Polak,et al.  Note sur la convergence de méthodes de directions conjuguées , 1969 .

[21]  Amy Lin,et al.  Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. , 2009, Cancer research.

[22]  N. Greenfield.  Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions , 2006, Nature Protocols.

[23]  M. Komiyama,et al.  Telomeric repeat-containing RNA structure in living cells , 2010, Proceedings of the National Academy of Sciences.

[24]  Kevin B. Turner,et al.  Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Ψ-RNA , 2006, Nucleic acids research.

[25]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[26]  G. Parkinson,et al.  A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex , 2010, Nucleic acids research.

[27]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[28]  Stefano Alcaro,et al.  Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? , 2014, Expert opinion on drug discovery.

[29]  Carlos González,et al.  Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening. , 2014, ACS chemical biology.

[30]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[31]  Stephen Neidle,et al.  Structural basis of DNA quadruplex recognition by an acridine drug. , 2008, Journal of the American Chemical Society.

[32]  Gavin W. Collie,et al.  The Application of DNA and RNA G‐Quadruplexes to Therapeutic Medicines , 2012 .

[33]  S. Balasubramanian,et al.  5′-UTR RNA G-quadruplexes: translation regulation and targeting , 2012, Nucleic acids research.

[34]  C. C. Hardin,et al.  Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine·guanine base pairs , 1987, Cell.

[35]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[36]  C. Azzalin,et al.  Telomeric Repeat–Containing RNA and RNA Surveillance Factors at Mammalian Chromosome Ends , 2007, Science.

[37]  F. Crick,et al.  A structure for deoxyribose nucleic acid , 2017 .

[38]  A. Phan,et al.  Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics. , 2003, Journal of the American Chemical Society.

[39]  Federica Moraca,et al.  Hit Identification of a Novel Dual Binder for h‐telo/c‐myc G‐Quadruplex by a Combination of Pharmacophore Structure‐Based Virtual Screening and Docking Refinement , 2016, ChemMedChem.

[40]  Simona Distinto,et al.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? , 2008, J. Comput. Aided Mol. Des..